Purpose: Individual-level simulation models often require sampling times to events, however efficient parametric distributions for many processes may often not exist. For example, time to death from life tables cannot be accurately sampled from existing parametric distributions. We propose an efficient nonparametric method to sample times to events that does not require any parametric assumption on the hazards. Methods: We developed a nonparametric sampling (NPS) approach that simultaneously draws multiple time-to-event samples from a categorical distribution. This approach can be applied to univariate and multivariate processes. The probabilities for each time interval are derived from the time interval-specific constant hazards. The times to events can then be used directly in individual-level simulation models. We compared the accuracy of our approach in sampling time-to-events from common parametric distributions, including exponential, Gamma, and Gompertz. In addition, we evaluated the method's performance in sampling age to death from US life tables and sampling times to events from parametric baseline hazards with time-dependent covariates. Results: The NPS method estimated similar expected times to events from 1 million draws for the three parametric distributions, 100,000 draws for the homogenous cohort, 200,000 draws from the heterogeneous cohort, and 1 million draws for the parametric distributions with time-varying covariates, all in less than a second. Conclusion: Our method produces accurate and computationally efficient samples for time-to-events from hazards without requiring parametric assumptions. This approach can substantially reduce the computation time required to simulate individual-level models.

The authors have declared no competing interest.

Dr. Alarid-Escudero is supported by the grant U01CA253913, Dr. Jalal is supported by a Canada Research Chair, and Drs. Alarid-Escudero and Jalal are supported by the grant U01CA265750 from the National Cancer Institute (NCI) as part of the Cancer Intervention and Surveillance Modeling Network (CISNET)

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes